No abstract available
MeSH terms
-
Benzhydryl Compounds / pharmacology
-
Benzhydryl Compounds / therapeutic use
-
Biomarkers / urine
-
Canagliflozin / pharmacology
-
Canagliflozin / therapeutic use
-
Diabetes Mellitus, Type 2 / diagnosis
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / urine
-
Glucosides / pharmacology
-
Glucosides / therapeutic use
-
Glycosuria / chemically induced*
-
Humans
-
Hypoglycemic Agents / pharmacology
-
Hypoglycemic Agents / therapeutic use*
-
Renal Elimination / drug effects*
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors*
Substances
-
Benzhydryl Compounds
-
Biomarkers
-
Glucosides
-
Hypoglycemic Agents
-
SLC5A2 protein, human
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors
-
Canagliflozin
-
dapagliflozin
-
empagliflozin